MG
Malik Gulabsab Shaikh
About Malik Gulabsab Shaikh
Data last updated:
Malik Gulabsab Shaikh has 5 years in corporate governance. Holds Director role. Currently with 2 companies, including Pollomi Pharmaceutical Private Limited and Venessa Pharma Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Pollomi Pharmaceutical Private Limited at ₹3.48 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 28 Apr 2021 | 2021 | ₹3.48 Cr (FY 2025) | Active | |
| Director | 01 Sep 2025 | 2025 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Malik Gulabsab Shaikh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Malik Gulabsab Shaikh
Malik Gulabsab Shaikh has 5 years in corporate governance. Holds Director role. Currently with 2 companies, including Pollomi Pharmaceutical Private Limited and Venessa Pharma Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Pollomi Pharmaceutical Private Limited at ₹3.48 Cr (FY 2025).
Malik Gulabsab Shaikh is associated with 2 companies as Director, including Pollomi Pharmaceutical Private Limited (₹3.48 Cr), Venessa Pharma Private Limited.
Malik Gulabsab Shaikh has expertise in General Business.
Malik Gulabsab Shaikh has 5 years in corporate governance.
By reported revenue, the largest current company of Malik Gulabsab Shaikh is Pollomi Pharmaceutical Private Limited, with revenue of ₹3.48 Cr (FY 2025).
Malik Gulabsab Shaikh currently holds positions at 2 companies: Pollomi Pharmaceutical Private Limited (₹3.48 Cr), Venessa Pharma Private Limited.